Sage Journals: Discover world-class research

Abstract

Background

Attention has turned to neurorestorative therapies, including erythropoietin, for experimental ischaemic stroke and head injury. Treatments for intracerebral haemorrhage need to be developed, as this represents a particularly devastating and common form of neurological injury.

Aim

The aim of this study is to investigate the therapeutic potential of erythropoietin after intracerebral haemorrhage in rats and to measure its effects on mechanisms of recovery and neurogenesis.

Methods

Intracerebral haemorrhage was induced in 24 Wistar male rats by intrastriatal infusion of autologous blood. Recombinant human erythropoietin (5000 or 10000 U/kg BW/day) or saline was administered starting 1 day after intracerebral haemorrhage and continued daily for 1 week (n = 8 for each group). To label proliferating cells, 5‘-bromo-2’ deoxyuridine was injected daily for 13 days after intracerebral haemorrhage. All animals survived for 2 weeks after intracerebral haemorrhage. Functional outcome, area of tissue loss and immunohistochemical staining were measured at 14 days after intracerebral haemorrhage. Global test or anova was used to test the erythropoietin dose effect.

Results

Rats receiving recombinant human erythropoietin after intracerebral haemorrhage exhibited significant improvement in modified neurological severity score and corner test at 14 days (P<0·05). Increased expression of phenotypes of synaptogenesis and proliferating immature neurons were shown by immunohistochemical staining. Only the group receiving a lower dose of recombinant human erythropoietin had significantly less tissue loss compared with the control group (P<0·05). In rats treated with recombinant human erythropoietin, double staining for 5‘-bromo-2’ deoxyuridine and TUJ1 revealed a subpopulation of cells that express an immature neuronal marker while still dividing.

Conclusions

Erythropoietin improves neurological outcome and increases histochemical parameters of neurogenesis when given after intracerebral haemorrhage in rats. Intriguingly, only the lower dose of recombinant human erythropoietin was effective in reducing tissue loss in the region of intracerebral haemorrhage.

Keywords

erythropoietin intracerebral haemorrhage neural regeneration

Get full access to this article

View all access options for this article.

References

1 Broderick

Connolly

Feldmann

. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007; 116:e391–413.

2 Fernandes

Siddique

Banister

. Continuous monitoring of ICP and CPP following ICH and its relationship to clinical, radiological and surgical parameters. Acta Neurochir 2000; 76(Suppl.): 463–6.

3 Hasselblatt

Ehrenreich

Siren

. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J Neurosurg Anesthesiol 2006; 18:132–8.

4 Seyfried

Ding

Han

Chen

Chopp

. Effects of intravenous administration of human bone marrow stromal cells after intracerebral hemorrhage in rats. J Neurosurg 2006; 104:313–8.

5 Wang

Zhang

Wang

Zhang

Chopp

. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004; 35:1732–7.

6 Chen

Zhang

. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003; 53:743–51.

7 Chopp

Zhang

. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 2000; 11:3001–5.

8 Wang

Zhang

. Neurogenin 1 mediates erythropoietin enhanced differentiation of adult neural progenitor cells. J Cereb Blood Flow Metab 2006; 26:556–64.

9 Wang

Zhang

. Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J Neurosci 2006; 26:5996–6003.

10.

10 Lu

Mahmood

Goussev

Schallert

Chopp

. Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma 2005; 22:1011–7.

11.

11 Schallert

Kozlowski

Humm

Cocke

. Use-dependent structural events in recovery of function. Adv Neurol 1997; 73:229–38.

12.

12 Shohami

Novikov

Bass

. Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res 1995; 674:55–62.

13.

13 Borlongan

Randall

Cahill

Sanberg

. Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test. Brain Res 1995; 676:231–4.

14.

14 Zhang

Schallert

Zhang

. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods 2002; 117:207–14.

15.

15 Chen

Wang

. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001; 32:1005–11.

16.

16 Feng

Walsh

. Protein-protein interactions, cytoskeletal regulation and neuronal migration. Nat Rev Neurosci 2001; 2:408–16.

17.

17 Bartesaghi

Marinovich

Corsini

Galli

Viviani

. Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology 2005; 26:923–8.

18.

18 Zhang

Cui

. Erythropoietin treatment improves neurological functional recovery in EAE mice. Brain Res 2005; 1034:34–9.

19.

19 Lee

Chu

Sinn

. Erythropoietin reduces perihemato-mal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. J Neurochem 2006; 96:1728–39.

20.

20 Zhang

LeTourneau

Gregg

. Neuroblast division during migration toward the ischemic striatum: a study of dynamic migratory and proliferative characteristics of neuroblasts from the subventricular zone. J Neurosci 2007; 27:3157–62.

21.

21 Kellert

McPherson

Juul

. A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats. Pediatr Res 2007; 61:451–5.

22.

22 Brines

Ghezzi

Keenan

. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000; 97:10526–31.

23.

23 Torup

. Neuroprotection with or without erythropoiesis; sometimes less is more. Br J Pharmacol 2007; 151:1141–2.

24.

24 Coleman

Westenfelder

Togel

. Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc Natl Acad Sci USA 2006; 103:5965–70.

25.

25 Mahmood

. Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin. J Neurosurg 2007; 107:392–7.

Erythropoietin Promotes Neurological Recovery after Intracerebral Haemorrhage in Rats

Abstract

Background

Aim

Methods

Results

Conclusions

Keywords

Get full access to this article

References